ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,217.68
0.07%
Dow Jones
39,487.89
0.25%
US Dollar vs MXN
16.7703
-0.14%
Brent Oil
83.035
-1.09%
Bitcoin
61,176.35
-2.97%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) Noticias

EOLS

Evolus (EOLS)

Evolus Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EOLS
FechaHoraFuenteTítuloSímboloCompañía
10/05/202408:10Business WireEvolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the YearNASDAQ:EOLSEvolus Inc
07/05/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/05/202415:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/05/202415:05Business WireEvolus Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:EOLSEvolus Inc
23/04/202415:30Business WireEvolus to Report First Quarter Financial Results on May 7, 2024NASDAQ:EOLSEvolus Inc
17/04/202415:05Business WireEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
12/04/202415:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
26/03/202407:00Business WireEvolus to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:EOLSEvolus Inc
11/03/202408:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EOLSEvolus Inc
11/03/202406:00Business WireEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common StockNASDAQ:EOLSEvolus Inc
07/03/202415:58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
07/03/202415:42Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
07/03/202415:05Business WireEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 GuidanceNASDAQ:EOLSEvolus Inc
01/03/202407:30Business WireEvolus Announces Results from European Head-to-Head Filler TrialNASDAQ:EOLSEvolus Inc
27/02/202407:30Business WireEvolus to Participate in Upcoming Leerink Partners and Barclays Investor ConferencesNASDAQ:EOLSEvolus Inc
23/02/202419:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
22/02/202415:30Business WireEvolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024NASDAQ:EOLSEvolus Inc
30/01/202415:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
16/01/202416:28Business WireEvolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 GuidanceNASDAQ:EOLSEvolus Inc
11/01/202405:18IH Market NewsWall Street Highlights: Mastercard’s Financial Rise, Citigroup’s $3.8 Billion Charges, and MoreNASDAQ:EOLSEvolus Inc
04/01/202415:05Business WireEvolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate CommunicationsNASDAQ:EOLSEvolus Inc
20/12/202307:00Business WireEvolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in EuropeNASDAQ:EOLSEvolus Inc
12/12/202304:50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:EOLSEvolus Inc
07/11/202315:16Business WireEvolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
06/11/202307:45Business Wire“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
01/11/202307:45Business WireEvolus to Participate in November Investor ConferencesNASDAQ:EOLSEvolus Inc
25/10/202307:45Business WireEvolus to Report Third Quarter 2023 ResultsNASDAQ:EOLSEvolus Inc
25/10/202307:45Business WireFinal Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
18/10/202315:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EOLSEvolus Inc
29/08/202307:45Business WireEvolus to Participate in September ConferencesNASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS

Su Consulta Reciente

NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
NYSE
MRK
Merck
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados